Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11407782 Oxysterols and methods of use thereof

Patent 11407782 was granted and assigned to SAGE Therapeutics on August, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

SAGE Therapeutics

Current Assignee

SAGE Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11407782

Patent Inventor Names

Boyd L. Harrison0

Gabriel Martinez Botella0

Francesco G. Salituro0

Albert Jean Robichaud0

Date of Patent

August 9, 2022

Patent Application Number

16930047

Date Filed

July 15, 2020

Patent Citations

‌

US Patent 10227375 Neuroactive steroids and methods of use thereof

‌

US Patent 10259840 Oxysterols and methods of use thereof

‌

US Patent 10723758 Oxysterols and methods of use thereof

‌

US Patent 10696712 Oxysterols and methods of use thereof

‌

US Patent 11149054 Oxysterols and methods of use thereof

‌

US Patent 11111266 Oxysterols and methods of use thereof

‌

US Patent 11104701 Neuroactive steroids and methods of use thereof

‌

US Patent 10759828 Neuroactive steroids, compositions, and uses thereof

...

Patent Citations Received

‌

US Patent 12129276 Oxysterols and methods of use thereof

Patent Primary Examiner

CPC Code

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11407782 Oxysterols and methods of use thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API